Acer Medical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-29.69	-27.36	-38.18	-54.71	-20.45
Depreciation & Amortization	1.24	0.57	0.72	0.48	0.06
Other Amortization	-	0.66	0.59	0.19	0.02
Loss (Gain) From Sale of Assets	-	-	0	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	0
Stock-Based Compensation	0.02	0.03	-	0.02	-
Other Operating Activities	-0.81	-2.95	-0.53	-0.06	-
Change in Accounts Receivable	-0.73	6.17	-4.5	-0.47	-4.09
Change in Inventory	-1.5	10.91	-12.13	0.76	-0.76
Change in Accounts Payable	0.73	-11.26	7.56	0.06	0.12
Change in Unearned Revenue	1.4	0.23	0.01	-1.02	1.02
Change in Other Net Operating Assets	4.69	2.31	-6.68	8.97	5.27
Operating Cash Flow	-24.65	-20.7	-53.13	-45.77	-18.82
Capital Expenditures	-	-	-	-3.2	-0.51
Sale of Property, Plant & Equipment	-	-	0.01	0.04	-
Cash Acquisitions	-	3.61	-	-	-
Sale (Purchase) of Intangibles	-	-	-0.76	-4.21	-0.36
Sale (Purchase) of Real Estate	-0.61	-	-	-	-
Investment in Securities	-2.5	-	-2.5	80	-80
Other Investing Activities	-1.37	-0.16	-0.15	-	-
Investing Cash Flow	-4.48	3.45	-3.4	72.63	-80.87
Short-Term Debt Issued	2.5	-	-	-	-
Total Debt Issued	2.5	-	-	-	-
Net Debt Issued (Repaid)	2.5	-	-	-	-
Issuance of Common Stock	-	-	-	200.01	106
Financing Cash Flow	2.5	-	-	200.01	106
Net Cash Flow	-26.63	-17.25	-56.53	226.88	6.32
Free Cash Flow	-24.65	-20.7	-53.13	-48.97	-19.32
Free Cash Flow Margin	-41.04%	-41.27%	-193.57%	-374.94%	-200.71%
Free Cash Flow Per Share	-1.62	-1.36	-3.49	-3.97	-2.49
Cash Income Tax Paid	-	0.34	0.23	0.01	-
Levered Free Cash Flow	-15.37	-11.08	-41.44	-32.95	-12.07
Unlevered Free Cash Flow	-15.36	-11.08	-41.44	-32.95	-12.07
Change in Working Capital	4.59	8.35	-15.73	8.3	1.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.